Xinmei Zhang
ORCID: 0000-0001-7122-6435
· 152 papers in corpus
other
2022
OBJECTIVE: This prospective cohort study aimed to compare the clinical efficacy and safety of goserelin 10.8 mg administered trimonthly with goserelin 3.6 mg administered monthly in premenopausal females with symptomatic adenomyosis. METHO…
other
2022
Although long non coding RNAs (lncRNAs) and circular RNAs (circRNAs) play important roles in the pathogenesis of diseases, endometriosis related lncRNAs and circRNAs are still rarely reported. This study focused on the potential molecular m…
observational
2022
Objective: To determine whether endometrioma recurrence is closely related to the presence of extrinsic adenomyosis, which was demonstrated by magnetic resonance imaging (MRI). Design: Observational crosssectional study involving patients w…
observational
2022
OBJECTIVE: This study aims to evaluate the factors associated with complications and long-term results in the surgical treatment of intestinal deep endometriosis and to figure out the optimized treatment measures for bowel endometriosis. M…
2022
lab-animal
2022
Objective: Due to high levels of serum gonadotropin-releasing hormone (GnRH), perimenopausal or menopausal women, girls with central precocious puberty, women of polycystic ovary syndrome, and females receiving long-term GnRH agonist (GnRHa…
lab-animal
2022
This investigation probed endometriosis treatment using targeted nanoparticles (NPs) to modulate autophagic activity. To that end, a novel form of polymer-based NP gene delivery platform consisting of polyethyleneimine (PEI) conjugated to s…
observational
2022
Objective: To study the 12-month effects and possible mechanisms of low-dose mifepristone in the treatment of adenomyosis. Methods: Patients included in this retrospective study had painful adenomyosis and previously received 5 mg mifeprist…
other
2022
Although many studies show that patients with diffuse adenomyosis who underwent fertility-sparing surgery can have a successful pregnancy, their pregnancy outcomes are still controversial. The objective of this study was to determine long-t…
other
2022
There is a high rate of inconformity between clinical staging and surgical-pathologic staging in endometrial cancer. Many patients with advanced endometrial cancer are preoperatively understaged and thereby do not receive the optimal therap…
observational
2022
Triptorelin is one of the most commonly used gonadotropin-releasing hormone agonists and has been used in the treatment of deep infiltrating endometriosis (DIE). This study aimed to evaluate the efficacy and safety of up to 24 weeks of trip…
lab-animal
2022
BACKGROUND: Many factors can affect the recurrence of endometriosis after surgery, however, whether endometriotic cyst fluid contributes to endometriosis recurrence after surgical excision of ovarian endometriomas remains unclear. The objec…
2021
Additional file 10: Table S9. List of differential genes in subtypes of mast cells.
2021
Additional file 10: Table S9. List of differential genes in subtypes of mast cells.
2021
Additional file 11: Table S10. Details of antibodies used in this study.
2021
Additional file 11: Table S10. Details of antibodies used in this study.
2021
Additional file 12: Table S11. Primer sequences for quantitative real-time PCR.
2021
Additional file 12: Table S11. Primer sequences for quantitative real-time PCR.
2021
Additional file 1: Figure S1. Diverse cell types in peritoneal fluid delineated by single cell transcriptomic analysis. Figure S2. Mean gene expressions of CCR2 and CD33 in the six macrophage subclusters. Figure S3. Gating strategy of flow …
2021
Additional file 1: Figure S1. Diverse cell types in peritoneal fluid delineated by single cell transcriptomic analysis. Figure S2. Mean gene expressions of CCR2 and CD33 in the six macrophage subclusters. Figure S3. Gating strategy of flow …
2021
Additional file 2: Table S1. Clinical characteristics of endometriosis and control patients in this study.
2021
Additional file 2: Table S1. Clinical characteristics of endometriosis and control patients in this study.
2021
Additional file 3: Table S2. Genes, UMIs counts, percentage of hemoglobin gene and percentage of mitochondrion for each individual cell.
2021
Additional file 3: Table S2. Genes, UMIs counts, percentage of hemoglobin gene and percentage of mitochondrion for each individual cell.
2021
Additional file 4: Table S3. The mean gene expression in each cluster of endometriosis (EMs) and control samples.